TSE:7875 stock news
This page provides real-time market news, earnings updates, and company announcements related to TAKEDA iP HOLDINGS CO. LTD. (TSE:7875).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-21 02:26 JST
Yen Continues to Weaken Despite Warnings from Katayama and Bessent
101 finance2026-01-13 08:51:23
Takaichi’s Initial Election Strategy in Japan Shakes Up Yen, Bonds, and Equities
101 finance2026-01-13 08:54:33
On the premier platform for biotechnology, revived enthusiasm faces a critical examination
101 finance2026-01-16 11:51:07
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Finviz2026-02-26 12:03:46
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Takeda Pharmaceutical and Protagonist Therapeutics Inc (NASDAQ: PTGX) jointly announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their co-developed drug Rusfertide and granted it priority review status.
老虎证券2026-03-02 07:36:04
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Finviz2026-03-02 13:03:55
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Finviz2026-03-05 18:57:53
FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment
Finviz2026-03-08 16:03:55
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Finviz2026-03-13 12:06:56
KROS: Does the Discounted Book Value Represent a Value Trap?
101 finance2026-03-17 18:27:51
KROS Pipeline Catalysts: DMD Phase II Progress and ALS Strategy for 2026
101 finance2026-03-17 18:27:52
Breakthrough in new drug development boosts market confidence: Ovid Therapeutics Inc. (NASDAQ: OVID) shares surged 26.4% in pre-market trading today after the company announced positive safety data for its experimental epilepsy drug OV935/TAK-935.
老虎证券2026-03-18 10:52:38
Take-Two’s release of GTA VI in May 2026 stands as the decisive turning point for value investors.
101 finance2026-03-19 17:43:04
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
Takeda Pharmaceutical and Protagonist Therapeutics Inc (NASDAQ: PTGX) jointly announced that the U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for their co-developed drug Rusfertide and granted it priority review status.
老虎证券2026-03-02 07:36:04
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Finviz2026-03-02 13:03:55
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Finviz2026-03-05 18:57:53
FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment
Finviz2026-03-08 16:03:55
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Finviz2026-03-13 12:06:56
KROS: Does the Discounted Book Value Represent a Value Trap?
101 finance2026-03-17 18:27:51
KROS Pipeline Catalysts: DMD Phase II Progress and ALS Strategy for 2026
101 finance2026-03-17 18:27:52
Breakthrough in new drug development boosts market confidence: Ovid Therapeutics Inc. (NASDAQ: OVID) shares surged 26.4% in pre-market trading today after the company announced positive safety data for its experimental epilepsy drug OV935/TAK-935.
老虎证券2026-03-18 10:52:38
Take-Two’s release of GTA VI in May 2026 stands as the decisive turning point for value investors.
101 finance2026-03-19 17:43:04
TSE:7875 stock price change
On the last trading day, TSE:7875 stock closed at 1325.00 JPY, with a price change of 0.45% for the day.
Trade stock perpsTSE:7875 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more